Spirit maker MGP Ingredients Q2 sales beat estimates

Reuters
07/31
Spirit maker <a href="https://laohu8.com/S/MGPI">MGP Ingredients</a> <a href="https://laohu8.com/S/QTWO">Q2</a> sales beat estimates

Overview

  • MGP Ingredients Q2 sales fall 24% to $145.5 mln, beating analyst expectations

  • Adjusted EPS drops 43% to $0.97, no analyst estimate provided

  • Co reaffirms 2025 sales and adjusted earnings outlook

Outlook

  • MGP Ingredients projects 2025 sales between $520 mln and $540 mln

  • Company expects adjusted EBITDA for 2025 between $105 mln and $115 mln

  • MGP Ingredients sees adjusted EPS for 2025 in the range of $2.45 to $2.75

  • Company revises full-year capital expenditures to approximately $32.5 mln

Result Drivers

  • BROWN GOODS DECLINE - Reduced customer demand for brown goods due to elevated industry-wide barrel inventories impacted sales, per co

  • PROACTIVE ENGAGEMENT - Brown goods sales volume and pricing met expectations due to proactive customer engagement

  • PREMIUM PLUS GROWTH - Penelope brand drove growth in premium plus sales within Branded Spirits segment

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$145.50 mln

$139.40 mln (6 Analysts)

Q2 Net Income

$14.40 mln

Q2 Adjusted EBITDA

$35.90 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the distillers & wineries peer group is "buy"

  • Wall Street's median 12-month price target for MGP Ingredients Inc is $39.50, about 25.6% above its July 30 closing price of $29.37

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nBwrnR8ta

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10